Genetic engineering of  for enhanced production of -10, -12 conjugated linoleic acid by unknown
Zhang et al. Microbial Cell Factories 2013, 12:70
http://www.microbialcellfactories.com/content/12/1/70RESEARCH Open AccessGenetic engineering of Yarrowia lipolytica for
enhanced production of trans-10, cis-12
conjugated linoleic acid
Baixi Zhang1†, Haiqin Chen2†, Min Li1,2, Zhennan Gu2, Yuanda Song2, Colin Ratledge3, Yong Q Chen1,
Hao Zhang2* and Wei Chen1*Abstract
Background: Conjugated linoleic acid (CLA) has been extensively studied for decades because of its health benefits
including cancer prevention, anti-atherogenic and anti-obesity effects, and modulation of the immune system. We
previously described the production of trans-10, cis-12 CLA in Yarrowia lipolytica by expressing the gene coding for
linoleic acid isomerase from Propionibacterium acnes (pai). However the stable strain produced CLA at about 0.08%
of dry cell weight (DCW), a level of production which was not high enough for practical applications. The goal of
the present study was to enhance production of CLA by genetic engineering of Y. lipolytica strains.
Results: We have now co-expressed the delta 12-desaturase gene (FADS12, d12) from Mortierella alpina together
with the codon-optimized linoleic acid isomerase (opai) gene in Y. lipolytica, expressed under the control of
promoter hp16d modified by fusing 12 copies of UAS1B to the original promoter hp4d. A multi-copy integration
plasmid was used to further enhance the expression of both genes. Using glucose as the sole carbon source, the
genetically-modified Y. lipolytica produced trans-10, cis-12-CLA at a level of up to 10% of total fatty acids and 0.4%
of DCW. Furthermore, when the recombinant yeast was grown with soybean oil, trans-10, cis-12-CLA now
accumulated at a level of up to 44% of total fatty acids, which represented 30% of DCW after 38.5 h of cultivation.
In addition, trans-10, cis-12-CLA was also detected in the growth medium up to 0.9 g/l.
Conclusions: We have successfully produced trans-10, cis-12-CLA with a titre of 4 g/l of culture (3.1 g/l in cells and
0.9 g/l in culture medium). Our results demonstrate the potential use of Y. lipolytica as a promising microbial cell
factory for trans-10, cis-12-CLA production.
Keywords: Conjugated linoleic acid, Fermentation, Multi-copy integration, opai-d12 co-expression, Promoter hp16d,
Soybean oil, Yarrowia lipolyticaBackground
Conjugated linoleic acids (CLA) are geometric and
positional dienoic isomers of linoleic acid (18:2, n-9).
Over the last three decades, CLA has been extensively
studied because of its health benefits including cancer
prevention, anti-atherogenic and anti-obesity effects,
and immune system modulation [1]. The multiple
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reproduction in any medium, provided the orthe two most studied isomers, with cis-9, trans-11 CLA
playing the most important role in the anticancer effects,
and trans-10, cis-12 CLA having a predominant effect on
weight management and prevention of atherogenesis [2,3].
For the purpose of research and applications in medicinal
and nutritional fields, each CLA isomer needs to be
available at high purity and in large quantity. However,
the chemically-produced CLA is a mixture of four
(8,10-, 9,11-, 10,12-, and 11,13-18:2) cis/trans positional
isomers [4]. As a result, biological processes to produce
single CLA isomers have been investigated [5-10]. To
date, the highest yield of cis-9, trans-11 CLA (10.5 mg/ml)
was obtained in Delacroixia coronata using trans-vaccenicLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bioprocess yield of the other isomer, trans-10, cis-12 CLA
was very low, with a mere 0.2 mg/ml in recombinant
Escherichia coli using exogenous linoleic acid (LA) as
substrate [9].
In our previous study [10], we constructed a de novo
trans-10, cis-12 CLA biosynthesis system by transforming
the oleaginous yeast,Yarrowia lipolytica, with the recombin-
ant linoleate isomerase gene (pai) from Propionibacterium
acnes. Codon usage optimization of pai and multi-copy
integration significantly improved the expression of the
linoleate isomerase gene in Y. lipolytica. The amount of
trans-10, cis-12 CLA reached 5.9% of total fatty acids,
and 0.23% of DCW [10]. However, the yeast strain with the
highest integrated copy number (24 copies) was unstable
and the yield of CLA gradually decreased to 0.08% of
DCW. This yield therefore was not high enough for
further development. In an attempt to further increase
trans-10, cis-12 CLA production, we genetically modified Y.
lipolytica to improve the expression of linoleate isomerase
gene, and modified fermentation conditions to increase
the concentration of the isomerase substrate, LA. In this
manner, the yield of trans-10, cis-12 CLA was improved
significantly.
Results
Construction of recombinant yeast strains
Polh-pINA1312-opai, the single-copy integration strain
with the codon-optimized opai gene described in our
previous study [10], was used as a control and as a model
strain to develop CLA high-producing recombinant
strains. To increase LA content in Y. lipolytica, the
delta12-desaturase gene (d12) was cloned from M.
alpina to construct opai -d12 co-expression cassettes.
Delta12-desaturase converted oleic acid (18:1) to LA (18:2).
Polh-pINA1312-opai-d12 was obtained by transforming
Polh with opai-d12 co-expression cassettes. To enhance
opai expression, the promoter, hp4d, was replaced by a
modified promoter, hp16d, located upstream of opai,
resulting in the recombinant strains Polh-pINA1312-spopai
and Polh-pINA1312-spopai-d12. Furthermore, the spopai -
d12 co-expression cassettes were also placed in a multi-
copy integration plasmid, pINA1292. The new multi-copy
integration cassette was transformed to obtain the strain
Polh-pINA1292-spopai-d12. Eight to twelve transformants
in each series were picked randomly and confirmed to be
all positive by PCR analysis.
opai / d12 copy numbers in Polh-1292-spopai-d12
transformants
Twelve selected transformants with the multi-copy integra-
tion cassette derived from plasmid pINA1292-spopai-d12
were investigated. The copy numbers of the co-expression
cassettes were estimated using the data obtained by real-time PCR analysis. Y. lipolytica Polg was used as a control
organism with a single copy of both ura3 and suc2 target
sequences. As ura3, opai and d12 coexisted in expression
cassettes, the copy numbers of three genes were con-
sidered to be equal. Distribution of opai / d12 copy
numbers analyzed in twelve isolated transformants is
shown in Figure 1. For all the clones tested, copy numbers
fell in a narrow range of four to eight copies, with an aver-
age of five to six copies/cell. The strain with the highest copy
number was Polh-pINA1292-spopai-d12-16 (8 copies).
Effect of genetic modifications on opai transcript and
protein levels
Lipids and biomass of all transformants grown in YPD
medium were determined. For comparative analysis of
opai transcript and protein levels, five representative
transformants with an average CLA yield in each series
were selected, along with the best-performing transformant,
Polh-pINA1292-spopai-d12-16. Polh-pINA1312-opai-8 [10]
was used as the control strain. The opai transcript
levels in Polh-pINA1312- opai-d12-5 were similar to
those in the control strain (Figure 2). This suggested
that d12 overexpression driven by promoter hp4d did
not affect opai transcription. In contrast, the transcrip-
tion levels of opai in Polh-pINA1312-spopai-10 and
Polh-pINA1312-spopai-d12-9 were 3-fold higher than
in the control strain (Figure 2), which demonstrated that
the modified promoter hp16d was stronger in eliciting opai
transcription than hp4d. In addition, there was a 14.6-fold
increase in opai transcript levels in the multi-copy
integrated strain Polh-pINA1292-spopai-d12-7 (Figure 2),
suggesting that multi-copy integration could also increase
opai levels due to a gene dosage effect. As expected, the
best-performing transformant, Polh-pINA1292-spopai-
d12-16, had the highest opai mRNA level, corresponding
to a 21-fold increase compared with the control strain
(Figure 2). The opai protein levels in the six strains showed
a good correlation with the transcript levels (Figure 2).
Effect of genetic modifications on CLA production
To determine whether the above-described genetic modi-
fications had a positive effect on CLA production, the
recombinant Y. lipolytica strains were cultured in YPD for
72 h at 28°C. Lipids were then extracted and analyzed by
GC. CLA yields in different Y. lipolytica strains are
shown in Figure 2. Compared to the control strain
Polh-pINA1312-opai-8, expression of the heterologous
d12 and promoter modification increased CLA produc-
tion by 1.7- and 3-fold, respectively. Furthermore, the
combined effect of d12 expression and modified promoter
resulted in a 4.8-fold increase in CLA yield compared
to the control. The multi-copy integration of opai also
improved CLA yield: a 16-fold increase was observed
in Polh-pINA1292-spopai-d12-7 (7 copies), and a 20-
Figure 1 Relative copy numbers of integrated expression cassettes in Y. lipolytica multi-copy transformants. Real-time PCR was used to
estimate the copy numbers of the integrated expression cassettes among 12 Polh-1292-spopai-d12 transformants. Y. lipolytica Polg was used as a
control organism with a single copy of both the ura3 and suc2 target sequences. As ura3, opai and d12 coexisted in expression cassettes, the
copy numbers of three genes were considered to be equal. Error bars represent standard deviations from biological triplicates.
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transformant, Polh-pINA1292-spopai-d12-16 (8 copies),
compared to the control strain, Polh-pINA1312-opai-8.
Polh-pINA1292-spopai-d12-16 produced CLA to a level
of up to 9.8% (w/w) of total fatty acids, 0.38% (w/w) of
DCW, and 45 mg/l after 72 h cultivation in a shaking flask
with YPD medium (Table 1, Figure 2).
Fatty acid analysis (Table 1) showed that in all strains
containing recombinant delta12-desaturase, a large pro-
portion of oleic acid (OA) had been converted to LA, which
was now the major fatty acid. In addition, delta9,12-16:2
was detected as a new fatty acid in opai-d12 co-expressing
strains, suggesting that the delta12-desaturase can also use
16:1 as substrate [11].Figure 2 Transcript and protein levels of recombinant PAI and CLA yi
transcription and protein expression levels, five representative transformant
the best-performing transformant, Polh-pINA1292-spopai-d12-16. The Y. lipo
Transcript levels were determined by real-time PCR and protein levels were
The control used was the strain transformed with the empty vector pINA13Transformants are stable
The stability of the recombinant Y. lipolytica strains was
tested under nonselective conditions by culturing Polh-
pINA1292-spopai-d12-16 in YPD for 2 weeks (approxi-
mately 160 generations). No change was detected in the
copy numbers of opai, lipid content and fatty acid compo-
sitions of Polh-pINA1292-spopai-d12-16 obtained in YPD
(data not shown), indicating that the best-performing
transformant was stable even after 160 generations.
Production of CLA by fermentation in YNBD-SO media
As Y. lipolytica can utilize hydrophobic materials, such as
plant oils, as carbon source [12] and soybean oil contains
a high proportion of LA (60% of total fatty acids, Table 2,eld in different Y. lipolytica strains. For comparative analysis of opai
s with an average CLA yield in each series were selected, along with
lytica strains were harvested after 72 h cultivation in YPD medium.
analyzed by western blot analysis using specific polyclonal antibodies.
12. The standard deviations were < 5% of the values shown.














16:0 8.2 ± 0.4 11.2 ± 0.3 9.5 ± 0.6 11.8 ± 0.9 13.9 ± 0.7 13.3 ± 0.5
16:1 11.3 ± 0.7 6.4 ± 0.8 11.3 ± 1.2 10.5 ± 0.7 12.4 ± 0.8 10.7 ± 1.1
16:2 ND 2.6 ± 0.3 ND 1.0 ± 0.0 0.7 ± 0.1 0.4 ± 0.0
17:1 2.2 ± 0.2 2.3 ± 0.1 2.1 ± 0.1 2.4 ± 0.2 2.5 ± 0.2 2.4 ± 0.3
18:0 0.3 ± 0.0 1.3 ± 0.1 1.2 ± 0.0 1.3 ± 0.2 0.6 ± 0.0 1.1 ± 0.1
18:1 49.7 ± 2.0 13.2 ± 0.5 48.8 ± 1.6 25.9 ± 1.2 21.9 ± 0.8 26.4 ± 1.0
18:2 27.8 ± 1.1 62.2 ± 2.2 26.0 ± 1.3 44.8 ± 1.7 40.3 ± 0.9 35.9 ± 0.5
10 t, 12c-CLA 0.4 ± 0.1 0.7 ± 0.1 1.1 ± 0.2 2.2 ± 0.4 7.8 ± 0.7 9.8 ± 0.5
TFA (% of DCW) 4.2 ± 0.2 4.0 ± 0.1 4.8 ± 0.4 4.5 ± 0.2 3.7 ± 0.1 3.9 ± 0.3
Values are presented as % (w/w) of the total fatty acid levels in yeast transformants. The means ± SD were obtained from three independent experiments.
TFA, total fatty acid levels; ND, not detected.
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CLA by the best-performing strain was carried out in a
5 L fermenter with YNBD-SO medium [YNBD medium
containing 2% (w/v) soybean oil].
As shown in Figure 3, the cells were in a rapid growth
phase from 0 to 38.5 h, with lipid-free biomass concen-
tration increasing from 0.1 g/l to 17.1 g/l (Figure 3A).
During that time, glucose was consumed rapidly and
depleted by 24 h. Afterwards, the culture was in stationary
phase from 38.5 h to 120 h, followed by a decline phase
until the end of cultivation (168 h). Both biomass and
growth medium were extracted for lipid analysis. Lipid
content of the growth medium decreased from 18.7 g/l
(the added soybean oil) to zero during the first 60 h of
cultivation, indicating complete consumption of the soy-
bean oil (Figure 3C). Meanwhile, total lipid and CLA inTable 2 Fatty acid composition in cellular and
extracellular lipids of Polh-1292-spopai-d12-16 in










16:0 12.2 ± 0.6 9.3 ± 0.4 9.9 ± 0.5 11.8 ± 0.6
16:1 7.9 ± 0.8 0.9 ± 0.1 ND ND
16:2 1.7 ± 0.2 ND ND ND
17:1 0.3 ± 0.0 ND ND ND
18:0 0.9 ± 0.1 3.6 ± 0.2 3.5 ± 0.1 6.3 ± 0.3
18:1 15.7 ± 1.0 20.2 ± 0.7 19.4 ± 0.9 23.0 ± 1.2
18:2 60.6 ± 2.6 14.6 ± 0.6 57.5 ± 2.2 22.5 ± 0.7
18:3 ND 3.4 ± 0.1 8.0 ± 0.5 2.1 ± 0.3
10 t, 12c-CLA 0.3 ± 0.0 44.3 ± 2.1 ND 30.4 ± 1.1
Values are presented as % (w/w) of the total fatty acid levels in
Polh-1292-spopai-d12-16. Other fatty acids were C12:0, C14:0, C20:0, C20:1,
C20:2, C22:0 and C24:0 (not shown). The means ± SD were obtained from
three independent experiments. ND, not detected.cells increased and reached peaks of 35% and 16% (w/w)
of DCW, respectively, at 34 h (Figure 3B). The maximum
CLA titre in cells was 3.1 g/l both at 34 h and 38.5 h
(Figure 3B). Interestingly, CLA was also detected in
the growth medium (Figure 3C). During the rapid
growth phase, CLA content in growth medium increased
continuously and the maximum CLA titre of 0.9 g/l was
obtained at 38.5 h. After this time, CLA in cells and
growth medium decreased sharply until no more CLA
was detected at 168 h and 60 h, respectively.
The fatty acid compositions of cells and culture
medium at 0 and 38.5 h of cultivation are shown in
Table 2. The LA contents in cells and growth medium
decreased from 61% to 15% and from 58% to 23%,
respectively. In contrast, the CLA contents in cells and
growth medium increased from 0.3% to 44% and zero to
30% respectively, suggesting that LA in the soybean oil
added to the medium was efficiently converted to CLA
by PAI. In addition, lipid analysis of culture medium at
38.5 h of cultivation revealed that extracellular CLA
existed exclusively in free fatty acid form. At the same
time point, about 90% of the intracellular CLA existed
in free fatty acid form. Total CLA production in the
fermenter using YNBD-SO was almost 4 g/l, about 90
times higher compared to that using YPD medium in
shaking flask cultures (45 mg/l, Figure 2).
PAI activity in culture supernatant
To determine whether the CLA detected in culture
medium was due to PAI secretion, LA isomerase activity
was tested in the growth medium. Yeast cultures were
harvested after 24 h by centrifugation. One ml of cell-free
medium supplemented with 400 μg free LA (as the
substrate for PAI [7]) was incubated at 37°C for 1 h,
and then extracted for lipid analysis. The data showed
that no LA had been converted to CLA. This suggested
PAI secretion had not occurred.
Figure 3 Growth characteristics, lipid content and CLA
production of Y. lipolytica Polh-1292-spopai-d12-16 in batch
fermentations with YNBD-SO medium. The best-performing
strain, Polh-1292-spopai-d12-16, was cultivated in YNBD-SO medium
for 168 hours under fermentation conditions. (A) The growth of Y.
lipolytica was represented by lipid-free biomass calculated after
subtraction of the cellular lipids from the total biomass. The glucose
concentration was quantified using glucose oxidase in a standard
glucose assay kit. (B), (C) Time course of lipid and CLA contents in
cells and culture medium. Lipid and CLA yields in cells are expressed
as percentage of total DCW. CLA titre in cells and medium and lipid
titres in medium are expressed as g/l. The values represent the
mean ± SD of three replicates.
Figure 4 Cell morphology of Y. lipolytica Polh-1292-spopai-d12-16.
Cells were harvested after 24 h of cultivation in YNBD-SO medium.
Optical microscopy analysis was performed to determine the integrity
of Y. lipolytica cells under an Olympus System Microscope Model BX51.
The images are presented at a 400× magnification.
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To determine if the extracellular CLA was due to leakage
from the cells, cell integrity of the best-performing strain
in YNBD-SO medium was determined using microscopy.
As Figure 4 shows, no obvious cell lysis had occurred, anda mixture of yeast-like and short mycelial cells were
present at 24 h of fermentation in YNBD-SO.
Discussion
In our previous study, we constructed a de novo CLA bio-
synthesis system by transforming the oleaginous yeast, Y.
lipolytica, with the recombinant linoleate isomerase gene
from P. acnes [10]. The expression level of opai was
increased by the optimization of the codon-usage of pai
and multi-copy integration of the gene. The average copy
numbers of opai in pINA1292-opai transformants were
12–13 copies/cell, with a maximum of 24 copies/cell, in
a strain which was unstable after a few passages of cultiva-
tion, and the copy number decreased to 7 copies/cell.
In this study, the average copy number of opai integrated
in cells using a multi-copy integration vector was estimated
at 5–6 copies/cell. The lower number of integrated copies
obtained in the present work might result from the much
longer integrated fragments (7827 bp) than in previous
study (4311 bp). In this study, the best-performing strain,
Polh-pINA1292-spopai-d12-16, which contained 8 copies
of the expression cassette, remained stable in copy
numbers and CLA yields (9.8% of total fatty acids).
This is consistent with a previous study showing that an
average of 10 copies/cell was stable in the Polh-pINA1292
expression system [13]. In addition to multi-copy integra-
tion, enhanced function of the promoter can also increase
the expression level of opai, which appears to be one
of the bottlenecks for CLA production in recombinant
Y. lipolytica.
Another potential bottleneck for CLA production in this
system is the intracellular concentration of the substrate,
LA. Our study showed that co-expression of d12 with opai
increased the LA content in cells from 28% to 62% of
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only slightly (from 0.4% to 0.7%) (Table 1). A possible
explanation is that the LA being produced by the delta12-
desaturase is in an esterified form, which is not a substrate
for PAI. An in vitro study has demonstrated that PAI,
unlike fatty acyl desaturases and fatty acyl elongases,
uses free fatty acid as its only substrate [8]. However,
the accumulation of esterified LA may contribute to a
slightly increased intermediate pool of free LA and
indirectly increase CLA production.
Because PAI is a soluble protein in the cytoplasm, it
may compete for the free LA with other cytosolic enzymes
that convert free LA to esterified forms of LA (methyl-,
CoA-, etc.) in various pathways including oxidation, desat-
uration, elongation or re-esterification [14]. Competition
for the same substrate by the enzymes involved in these
pathways may then limit the flux of free LA towards CLA
production. Hence, the overall efficiency of the CLA
synthesis depends on the expression level of PAI and free
LA content in Y. lipolytica.
In addition, a decrease in LA content (from 62% to
45%) in the opai-d12 co-expression strain was found
when the hp4d promoter located upstream of opai was
replaced by the hp16d enhanced promoter. The hp4d
promoter comports 4 copies of the UAS1B enhancer site
upstream of the core promoter, whereas hp16d has 16
UAS1B copies. This decrease in LA is probably due to pro-
moter interference between hp16d driving the opai and the
weaker hp4d promoter driving the d12-desaturase gene.
Due to its ability to hydrolyze extracellular lipids, Y.
lipolytica has been efficiently cultivated on various hydro-
phobic substrates such as alkenes or lipids to produce
many extra- or intra-cellular metabolites of industrial
significance [12]. Indeed, in this study, soybean oil,
which is rich in LA, was immediately hydrolyzed and
absorbed by Y. lipolytica and free LA was efficiently
converted to CLA. This suggests that exogenous LA is a
good substrate for PAI, unlike de novo synthesized LA.
Additionally, about a quarter of the total CLA production
was recovered in the growth medium. As no PAI extracel-
lular activity could be detected in the culture supernatant,
these results suggest that CLA present in the medium was
not a result of secreted PAI. Furthermore, no cell
fragmentation was observed, indicating that CLA was not
liberated into the medium by cell lysis. In addition, lipid
analysis revealed that the extracellular CLA was in the free
fatty acid form.
A possible mechanism that may account for the appear-
ance of CLA in the growth medium is that hydrolysis of
the oil, due to the very high activity of lipases in this yeast,
may produce free fatty acids faster than they can be incor-
porated into triacylglycerols and other intracellular lipids.
Consequently, as the cell does not accumulate free fatty
acids, the latter have to be pumped out of the cells andthus appear in the culture medium as free fatty acids,
which include the newly-synthesized CLA. As all the
enzymes involved in fatty acid metabolism, including
the linoleate isomerase, are able to act on the fatty acids
in exogenous soybean oil, CLA production is significantly
increased. If Y. lipolytica could be coaxed into continu-
ously secreting CLA, this transformed yeast strain would
be an efficient cell factory able to convert low-cost plant
oils into valuable CLA which can be directly collected from
the culture medium without biomass extraction processes.
Conclusion
We constructed a Y. lipolytica strain able to produce large
quantities of trans-10, cis-12-CLA. This was achieved by
combining different genetic engineering approaches
to enhance PAI expression and to increase substrate
availability.
When the final transformant was cultivated in medium
supplemented with soybean oil, 3.1 g CLA/l (16% of DCW)
was produced in cells with an additional 0.9 g CLA/l in the
growth medium. This result is the highest production of
trans-10, cis-12-CLA to date and shows promise for its
large-scale production.
Methods
Strains and culture conditions
The auxotrophic strain Y. lipolytica Polh [15] was used as
the PAI expression host, while Y. lipolytica Polg was used
as a control strain for real-time PCR. Y. lipolytica strains
were kindly provided along with the plasmids pINA1312
and pINA1292 [16] by Prof. Catherine Madzak (Institute
National de la Recherche Agronomique/AgroParisTech,
France). Escherichia coli DH5α was used for routine sub
cloning and plasmid propagation.
Media and growth conditions for E. coli were described
by Sambrook et al. [17], and those for Y. lipolytica were
described by Barth and Gaillardin [18]. YPD and YNBD
media were prepared for Y. lipolytica as described previ-
ously [18]. YPD contained 1% (w/v) yeast extract, 2% (w/v)
peptone and 2% (w/v) dextrose. YNBD contained 0.17%
(w/v) yeast nitrogen base (without amino acids and am-
monium sulphate), 0.5% (w/v) ammonium sulphate and
2% (w/v) dextrose. YNBD-SO medium used for fermenta-
tion is YNBD with 0.15% yeast extract, 0.5% (w/v) NH4Cl,
0.01% (w/v) uracil, 2% (w/v) Casamino acids and 2% (w/v)
soybean oil. 2% (w/v) soybean oil in 0.02% (w/v) Tween 80
was prepared as a 10-X sonicated stock emulsion and
sterilized by filtration through a 0.22 μm membrane [19].
Typically, cultivation was performed as follows. From
YNBD plates, Y. lipolytica transformants were grown in
YNBD (10 ml in 50 ml Erlenmeyer flasks, 200 rpm, 28°C,
48 h). These pre-cultures were inoculated into YPD (50 ml
in 250 ml Erlenmeyer flasks) to an OD600 of 0.1 and
further cultured for another 72 h at 28°C and 200 rpm.
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and washed once with de-ionized water, and the pellets
were either directly used for real-time PCR and western
blot analysis or lyophilized for biomass determination and
lipid analysis.
For fermentation experiments, a seed culture was grown
in YNBD (150 ml in 500 ml Erlenmeyer flasks, 200 rpm,
28°C, 48 h). The 150 ml seed culture was used to inoculate
3 l YNBD-SO containing 2% (w/v) soybean oil in a
fermenter (5 l, BioFlo Celligen 115, New Brunswick).
The fermentation was run at 28°C for 7 days. The aeration
was at 3 l/min and the stirrer was set at 500 rpm. The pH
was maintained at 6.0 with either 3 M KOH or 2 M
H2SO4. Silicone oil was periodically added as an antifoam
agent. Ten ml samples were taken at intervals. Cells were
harvested by centrifugation (8000 g, 15 min) and washed
twice with 0.85% (w/v) NaCl and the pellets were lyophi-
lized for biomass determination and lipid analysis. The
lipid-free biomass was calculated after subtraction of the
cellular lipids from the total biomass. The cell-free culture
was used for the LA isomerase activity assay, and heated
at 80°C for 10 min (to inactivate lipases) for the glucose
concentration assay and lipid analysis.
Plasmids construction and transformation
Standard protocols were followed for DNA manipulation
[17]. Vector pINA1312 and pINA1292 both contain
hp4d promoter which comprised four tandem UAS1B
copies upstream from a minimal leucine promoter. Previ-
ously, UAS1B was found to be an enhancer element and
hybrid promoters containing multiple UAS1B sequences
successfully amplified the expression levels of hrGFP and
lacZ [20,21]. In this study, the hp16d promoter was
constructed by fusing 12 tandem UAS1B enhancer se-
quences to the hp4d promoter. The four tandem UAS1B
sequence fragment, UAS1B4 was synthesized (Genscript,
Nanjing, China), flanked with ClaI-HindIII-SpeI sites
on the 5′-end and MluI-XbaI sites on the 3′-end. The
synthetic UAS1B4 sequence was inserted into pUC57
to form pUC-UAS1B4. The UAS1B4 fragment was extracted
from pUC-UAS1B4 by digestion with HindIII and XbaI
restriction enzymes and ligated with pUC-UAS1B4 cut
with HindIII and SpeI, resulting pUC-UAS1B8. The
construction of pUC-UAS1B12 was performed following
the same procedures used in the case of pUC-UAS1B8.
The UAS1B12 fragment was extracted from pUC-UAS1B12
by digestion with ClaI and MluI restriction enzymes
and inserted into pINA1312 and pINA1292 to form
pINA1312sp and pINA1292sp, respectively. The codon-
optimized LA isomerase sequence (opai) [10] was
digested with PmlI and KpnI and then inserted into
pINA1312sp and pINA1292sp to form pINA1312-sp
oPAI and pINA1292-spoPAI. The delta 12-desaturase
sequence (FADS12, d12) was isolated from Mortierellaalpina ATCC 32222 cDNA by PCR as previously described
[22]. The primers for delta12-desaturase amplification
were d12f: (5′-CCGCACGTGATGGCACCTCCCAAC
A-3′) and d12r: (5′-GGGGTACCTTACTTCTTGAAA
AAGACCACG-3′). After amplification, the PCR prod-
uct was digested with PmlI and KpnI and ligated with
pINA1312 to form pINA1312-d12. The d12 expression
cassette fragment containing the hp4d promoter, flanked
with EcoRI, was amplified using pINA1312-d12 as tem-
plate, with primers d12Expf (5′-GGAATTCTATCGATA
CGCGTGCATGCTGAG-3′) and d12Expr (5′-CATGGG
ACACGGGCATCTC-3′). The d12 expression cassette frag-
ment was digested with EcoRI and ligated with pINA1312-
opai, pINA1312-spopai and pINA1292-spopai, resulting
in the expression vectors pINA1312-opai-d12, pINA1312-
spopai-d12 and pINA1292-spopai-d12, respectively. All
newly constructed plasmids were screened by restriction
enzyme digestion and PCR, and then confirmed by DNA
sequencing.
Four new expression cassettes from the plasmids
constructed above were transformed into Y. lipolytica
strain Polh, resulting in four recombinant strains,
Polh-pINA1312-opai-d12, Polh-pINA1312-spopai, Polh-
pINA1312-spopai-d12 and Polh-pINA1292-spopai-d12.
Transformation was performed by the lithium acetate
method, as described previously [18]. Transformants were
selected by plating on YNBD.
Real-time PCR and western blotting
Real-time PCR was used to determine the transcript level
of opai and estimate the copy number of the expression
cassettes. The DNA, RNA extraction and real-time PCR
were performed as described elsewhere [23,24]. The pri-
mer sequences encoding the opai were: opaiF (5′-TCC
CGATTACGCTGACAAGAC-3′) and opaiR (5′-CTCCA
TGTCATCCAGCACCAT-3′). Western blot analysis was
used to determine the expression level of PAI protein and
carried out according to methods described previously [10].
Lipid extraction and fatty acid analysis
The cells, grown in YPD medium, were collected by centri-
fugation (6000 g, 5 min) and washed once with deionised
water, and the pellet was lyophilized prior to lipid
extraction. The cells, grown in YNBD-SO medium, were
collected by centrifugation (8000 g, 15 min), washed
twice with 0.85% w/v NaCl-0.5% bovine serum albumin
solution and the pellet was lyophilized. The cell-free
culture and washing solution were combined for lipid ex-
traction. Lipids from the equivalent weight of freeze-dried
cells (20 mg) were directly transmethylated with 10% (v/v)
methanolic HCl at 50°C for 3 h [10]. The lipids in medium
were extracted twice with a mixture of chloroform/
methanol (1:1) and total fatty acids in the medium were
similarly methylated with 10% (v/v) methanolic HCl. Free
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20 μL (trimethylsilyl)-diazomethane and 400 μL methanol
at 37°C for 30 min. Fatty acid methyl esters (FAMEs) were
analyzed by GC [10].
Stability of the transformants
Strains were grown in YPD for 2 weeks to keep the cells in
the exponential phase of growth throughout the experi-
ment. Cells were cultured in 20 ml of medium in 100-ml
shaking flasks. Every morning, fresh cultures were inocu-
lated at an initial A600 of 0.5 and grown for 8 h. In the
evening, fresh cultures were inoculated at an initial A600
of 0.2 and grown for 16 h. Samples of the previous culture
were used to inoculate the new culture. Under our growth
conditions, one cell generation corresponded to 2 h.
Determination of glucose concentration
Glucose was quantified by using glucose oxidase in a
standard glucose assay kit (RSbio, Shanghai. China).
Extracellular enzymatic activity assay
To determine extracellular LA isomerase activity in YNBD-
SO medium, 1 ml cell-free culture, with or without 400 μg
free LA, was incubated for 1 h at 37°C. Fatty acids from
the reaction system were extracted, methylated and
analyzed via GC as described above.
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